TPG to exit Immucor through $2bn sale to Werfen
Werfen, a global developer, manufacturer and distributor of specialised diagnostic instruments, is to acquire Immucor, Inc, a US-based specialist in transfusion and transplant in vitro diagnostics, from private equity firm TPG for approximately $2 billion. The acquisition, which is subject to customary regulatory approvals, is being funded with a mix
